June 2019

• Early diagnosis is key in the rare cancer linked to textured breast implants
  Solicitor Zahra Nanji is currently investigating a legal claim for over 350 women who have Allergan textured breast implants which have been linked to a rare form of cancer known as BIA-ALCL 30 June 2019
• Dispatches breast implant scandal investigation – what was missing from the MHRA response?
  Channel 4’s Dispatches documentary series last night explored ‘Britain’s Breast Implant Scandal’. One of the issues raised in the show was the link between textured breast implants and a rare form of cancer known as BIA-ALCL. Solicitor Sarah Moore featured in the programme and is currently investigating a legal case on behalf of women with Allergan textured implants and those with confirmed BIA-ALCL diagnoses. 25 June 2019
• Why words matter, Boris
  As Boris Johnson’s actions rightfully come under increasing public scrutiny, human rights solicitor Sean Humber discusses the importance of critically examining the language that he uses. 24 June 2019
• Beating a Part 36 offer, consequences, severability and penalties
  Head of clinical negligence Suzanne White and solicitor Matthew Westlake discuss their recent successful appeal of the decision by the Senior Courts Costs Office (SCCO) regarding Part 36 offers. 24 June 2019
• Allergan Implants: The Story so Far….
  Product liability solicitor, Sarah Moore, discusses the developments that have happened since French regulator ANSM recommended a permanent ban on the sale of Allergan implants. 10 June 2019
• Settlement following “Mickey Mouse” degree claim could lead to further claims against Universities
  Consumer law solicitor Harriet Bass discusses the recent case of Pok Wong who secured an out of court settlement from her former University after claiming that it had overpromised on the career prospects resulting from her degree. 7 June 2019
• Health Canada suspends licences for Allergan’s Biocell breast implants
  Solicitor Zahra Nanji discusses the recent announcement by Health Canada to suspend licences for Allergan’s Biocell breast implants, due to concerns about links to a rare form of cancer, and whether this should lead to stronger action from the UK health regulator. 4 June 2019